Global Health Imperatives
CGH's imperatives advance care and research focused on reducing current and growing global disease burdens, such as in oncology, infectious disease and women's health, and in accelerating the pace of biomedical innovation in under-resourced settings through rapid biomedical technology adaptation and use.
You can support these efforts by contributing today.
The Center for Global Cancer Medicine at Penn's Abramson Cancer Center is one of a select group of cancer centers in the US awarded the prestigious designation of Comprehensive Cancer Center by the National Cancer Institute. The Cancer Center and its affiliated hospitals provide customized care for every patient, including breakthrough treatment options like vaccine therapy and proton therapy that are available in only a few places in the world.
Penn has a strong clinical and research focus on women's wellness and pediatric care. Our clinicians, educators and researchers are engaged in these life-saving and high-impact arenas both domestically and abroad. In addition, the Center for Global Women’s Health (CGWH) is an interdisciplinary effort based in the School of Nursing that brings together faculty and students who collaborate on women's health scholarship, education, and clinical practice relevant to global issues.
Mobile health (mHealth) uses mobile technologies as tools and platforms for health research and healthcare delivery. mHealth tools or interventions can prove particularly useful in low resource settings, to address chronic disease or an array of other health issues, emphasizing the evaluation of health-related outcomes. The Penn Medicine Center for Health Care Innovation oversees the work of the Penn Social Media and Health Innovation Lab, an entity that conducts and disseminates multidisciplinary research at the intersection of social media, mobile technology, and health. mHealth Labs brings together medical, engineering and nursing students to work together to develop and test technologies to improve health care delivery.
The Penn ID Division is recognized for excellence in clinical care, research, and education. The expertise of the Division's faculty is complementary to our strong inpatient and outpatient programs in HIV medicine; infections in solid organ and bone marrow transplant recipients; healthcare epidemiology and antimicrobial stewardship; antimicrobial resistance; viral hepatitis; tuberculosis; travel medicine; and global health. In addition, our faculty are nationally and internationally renowned leaders in scientific investigation including bench science, translational and epidemiologic research, clinical trials, health policy, and public health. Our faculty are also known for their teaching excellence, traditionally capturing numerous School of Medicine teaching awards each year. In addition, the success of our faculty is recognized by the fact that numerous individuals hold leadership positions within national and international organizations, guidelines panels, and scientific committees. While most faculty members are based in Philadelphia, many are also based abroad, primarily within the Botswana-University of Pennsylvania Partnership, a unique multi- and inter-disciplinary clinical and research collaboration.